UB Paderborn / Katalog / Suche / in CDI

In memoriam of Rafael Molina (27 September 1955 - 26 July 2020)

Tumor biology, 2021-05, Vol.43 (1), p.97-98

2021

Link zum Volltext

Verfügbarkeit prüfen

Pro-Gastrin-Releasing Peptide (ProGRP)-A Diagnostic Biomarker for Small-Cell Lung Cancer

Zhongguo fei ai za zhi, 2009-03, Vol.12 (3), p.183-186

Stieber, Petra

2009

Link zum Volltext

Verfügbarkeit prüfen

Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy: HMGB1, sRAGE, DNAse and circulating nucleosomes in PC

International journal of cancer, 2013-06, p.n/a

2013

Link zum Volltext

Verfügbarkeit prüfen

CEA, CA15.3 and 18-FDG PET in the follow-up of early breast cancer (BC) patients (pts): A prospective, multicentric, randomized trial—KRONOS patient-oriented new surveillance study Italy

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS11627-TPS11627

2017

Link zum Volltext

Verfügbarkeit prüfen

The reality in the surveillance of breast cancer survivors-results of a patient survey

Breast cancer : basic and clinical research, 2008-01, Vol.1, p.17-23

2008

Link zum Volltext

Verfügbarkeit prüfen

The Reality in the Surveillance of Breast Cancer Survivors-Results of a Patient Survey

Breast cancer : basic and clinical research, 2008-01, Vol.2008 (1), p.BCBCR.S511

2008

Link zum Volltext

Verfügbarkeit prüfen

Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer

Tumor biology, 2008-09, Vol.29 (4), p.272-277

2008

Link zum Volltext

Verfügbarkeit prüfen

Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® OV Monitor assay on the UniCel® DxI 800 Immunoassay System

Clinical chemistry and laboratory medicine, 2008-05, Vol.46 (5), p.588-599

2008

Link zum Volltext

Verfügbarkeit prüfen

Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® BR Monitor assay on the UniCel® DxI 800 Immunoassay System

Clinical chemistry and laboratory medicine, 2008-05, Vol.46 (5), p.612-622

2008

Link zum Volltext

Verfügbarkeit prüfen

Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System

Clinical chemistry and laboratory medicine, 2008-05, Vol.46 (5), p.600-611

2008

Link zum Volltext

Verfügbarkeit prüfen

OPG Is Regulated by β-Catenin and Mediates Resistance to TRAIL-lnduced Apoptosis in Colon Cancer

Clinical cancer research, 2008, Vol.14 (15), p.4713-4718

2008

Link zum Volltext

Verfügbarkeit prüfen

Sinnvoller Einsatz von Tumormarkern / Sensible use of tumor markers

Laboratoriumsmedizin, 2008-09, Vol.32 (5), p.339-360

2008

Link zum Volltext

Verfügbarkeit prüfen

Nudeosomes as a new prognostic marker in early cerebral stroke

Journal of neurology, 2007, Vol.254 (5), p.617-623

2007

Link zum Volltext

Verfügbarkeit prüfen

Determination of Soluble MICA in Serum as a Novel Marker for Tumor Stage and Metastasis

Blood, 2004-11, Vol.104 (11), p.1344-1344

2004

Link zum Volltext

Verfügbarkeit prüfen

Alternative antibody for the detection of CA19-9 antigen : a European multicenter study for the evaluation of the analytical and clinical performance of the Access® Gl Monitor assay on the UniCel® Dxl 800 Immunoassay System

Clinical chemistry and laboratory medicine, 2008, Vol.46 (5), p.600-611

2008

Link zum Volltext

Verfügbarkeit prüfen

Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Commentary

Clinical cancer research, 2006, Vol.12 (24)

2006

Link zum Volltext

Verfügbarkeit prüfen

Tumor markers in breast cancer – european group on tumor markers (EGTM) recommendations

Biomedicine & pharmacotherapy, 2008, Vol.62 (8), p.517-518

2008

Link zum Volltext

Verfügbarkeit prüfen

Sensible Use of Tumor Markers. Sinnvoller Einsatz von Tumormarkern

Laboratoriumsmedizin, 2001, Vol.25 (9-10), p.327-336

Stieber, Petra

2001

Link zum Volltext

Verfügbarkeit prüfen

Does brain specific 24 S-hydroxycholesterol in plasma indicate the disruption of the blood–brain barrier in patients with ischemic stroke?

Neuroscience letters, 2004, Vol.368 (2), p.201-204

2004

Link zum Volltext

Verfügbarkeit prüfen

P-436 ProGRP in serum enables diagnosis of small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S201-S201

2003

Link zum Volltext

Verfügbarkeit prüfen

Tumormarker

Onkologie (Heidelberg, Germany), 1998-11, Vol.4 (11), p.1067-1076

1998

Link zum Volltext

Verfügbarkeit prüfen

Performance Characteristics of Seven Neuron-Specific Enolase Assays

Tumor biology, 2007, Vol.28 (1), p.27-35

2007

Link zum Volltext

Verfügbarkeit prüfen

P-333 Release of nucleosomes and LDH from normal broncho-epithelial cells and malignant lung cancer cells during irradiation indicate in vitro radiosensitivity

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S176-S176

2003

Link zum Volltext

Verfügbarkeit prüfen

The 28th Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM 2000, September 8-13, 2000, Munich, Germany

Tumor biology, 2000, Vol.21

2000

Link zum Volltext

Verfügbarkeit prüfen

Sinnvoller Einsatz von Tumormarkern / Sensible use of tumor markers

Laboratoriumsmedizin, 2008-09, Vol.32 (5), p.339-360

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

In memoriam of Rafael Molina (27 September 1955 - 26 July 2020)

Pro-Gastrin-Releasing Peptide (ProGRP)-A Diagnostic Biomarker for Small-Cell Lung Cancer

Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy: HMGB1, sRAGE, DNAse and circulating nucleosomes in PC

CEA, CA15.3 and 18-FDG PET in the follow-up of early breast cancer (BC) patients (pts): A prospective, multicentric, randomized trial—KRONOS patient-oriented new surveillance study Italy

The reality in the surveillance of breast cancer survivors-results of a patient survey

The Reality in the Surveillance of Breast Cancer Survivors-Results of a Patient Survey

Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer

Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® OV Monitor assay on the UniCel® DxI 800 Immunoassay System

Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® BR Monitor assay on the UniCel® DxI 800 Immunoassay System

Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System

OPG Is Regulated by β-Catenin and Mediates Resistance to TRAIL-lnduced Apoptosis in Colon Cancer

Sinnvoller Einsatz von Tumormarkern / Sensible use of tumor markers

Nudeosomes as a new prognostic marker in early cerebral stroke

Determination of Soluble MICA in Serum as a Novel Marker for Tumor Stage and Metastasis

Alternative antibody for the detection of CA19-9 antigen : a European multicenter study for the evaluation of the analytical and clinical performance of the Access® Gl Monitor assay on the UniCel® Dxl 800 Immunoassay System

Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Commentary

Tumor markers in breast cancer – european group on tumor markers (EGTM) recommendations

Sensible Use of Tumor Markers. Sinnvoller Einsatz von Tumormarkern

Does brain specific 24 S-hydroxycholesterol in plasma indicate the disruption of the blood–brain barrier in patients with ischemic stroke?

P-436 ProGRP in serum enables diagnosis of small cell lung cancer

Tumormarker

Performance Characteristics of Seven Neuron-Specific Enolase Assays

P-333 Release of nucleosomes and LDH from normal broncho-epithelial cells and malignant lung cancer cells during irradiation indicate in vitro radiosensitivity

The 28th Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM 2000, September 8-13, 2000, Munich, Germany

Sinnvoller Einsatz von Tumormarkern / Sensible use of tumor markers

Aktive Filter

Suchergebnisse filtern